-
1
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002 ; 324 (7329). 71-86
-
(2002)
BMJ
, vol.324
, Issue.7329
, pp. 71-86
-
-
-
2
-
-
0035124920
-
Platelet-active drugs: The relationships among dose, effectiveness, and side effects
-
Patrono C, Coller B, Dalen JE, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest. 2001 ; 119 (suppl 1). 39S - 63S
-
(2001)
Chest
, vol.119
, Issue.SUPPL. 1
-
-
Patrono, C.1
Coller, B.2
Dalen, J.E.3
-
3
-
-
0037190695
-
Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events
-
Weisman SM, Graham DY. Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002 ; 162 (19). 2197-2202
-
(2002)
Arch Intern Med
, vol.162
, Issue.19
, pp. 2197-2202
-
-
Weisman, S.M.1
Graham, D.Y.2
-
4
-
-
63849141400
-
Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement
-
Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2009 ; 150 (6). 396-404
-
(2009)
Ann Intern Med
, vol.150
, Issue.6
, pp. 396-404
-
-
-
5
-
-
79451474588
-
Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: A guideline for healthcare professionals from the american heart association/american stroke association
-
Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2011 ; 42 (1). 227-276
-
(2011)
Stroke
, vol.42
, Issue.1
, pp. 227-276
-
-
Furie, K.L.1
Kasner, S.E.2
Adams, R.J.3
-
6
-
-
79251601596
-
Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association
-
Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011 ; 42 (2). 517-584
-
(2011)
Stroke
, vol.42
, Issue.2
, pp. 517-584
-
-
Goldstein, L.B.1
Bushnell, C.D.2
Adams, R.J.3
-
7
-
-
84866035006
-
-
2011
-
Brott TG, Halperin JL, Abbara S, et al. ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/ CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography. J Am Coll Cardiol. 2011 2011 ; 57 (8). 1002-1044
-
(2011)
J Am Coll Cardiol
, vol.57
, Issue.8
, pp. 1002-1044
-
-
Brott, T.G.1
Halperin, J.L.2
Abbara, S.3
-
8
-
-
84856794168
-
Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
-
Vandvik PO, Lincoff AM, Gore JM, et al. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 ; 141 (suppl 2). e637S - e668S
-
(2012)
Chest
, vol.141
, Issue.SUPPL. 2
-
-
Vandvik, P.O.1
Lincoff, A.M.2
Gore, J.M.3
-
9
-
-
84859793751
-
Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women
-
Rivera CM, Song J, Copeland L, Buirge C, Ory M, McNeal CJ. Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women. J Womens Health (Larchmt). 2012 ; 21 (4). 379-387
-
(2012)
J Womens Health (Larchmt)
, vol.21
, Issue.4
, pp. 379-387
-
-
Rivera, C.M.1
Song, J.2
Copeland, L.3
Buirge, C.4
Ory, M.5
McNeal, C.J.6
-
10
-
-
0030027846
-
Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes
-
Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: prescribed use and outcomes. Ann Intern Med. 1996 ; 124 (3). 292-298
-
(1996)
Ann Intern Med
, vol.124
, Issue.3
, pp. 292-298
-
-
Krumholz, H.M.1
Radford, M.J.2
Ellerbeck, E.F.3
-
11
-
-
0029866182
-
Patterns of aspirin use in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study
-
Shahar E, Folsom AR, Romm FJ, et al. Patterns of aspirin use in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J. 1996 ; 131 (5). 915-922
-
(1996)
Am Heart J
, vol.131
, Issue.5
, pp. 915-922
-
-
Shahar, E.1
Folsom, A.R.2
Romm, F.J.3
-
12
-
-
0034646206
-
Aspirin use is low among United States outpatients with coronary artery disease
-
Stafford RS. Aspirin use is low among United States outpatients with coronary artery disease. Circulation. 2000 ; 101 (10). 1097-1101
-
(2000)
Circulation
, vol.101
, Issue.10
, pp. 1097-1101
-
-
Stafford, R.S.1
-
13
-
-
72049091998
-
Use of antithrombotic agents among U.S. Stroke survivors, 2000-2006
-
Cheng EM, Cohen SN, Lee ML, Vassar SD, Chen AY. Use of antithrombotic agents among U.S. stroke survivors, 2000-2006. Am J Prev Med. 2010 ; 38 (1). 47-53
-
(2010)
Am J Prev Med
, vol.38
, Issue.1
, pp. 47-53
-
-
Cheng, E.M.1
Cohen, S.N.2
Lee, M.L.3
Vassar, S.D.4
Chen, A.Y.5
-
14
-
-
3042512305
-
Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System
-
Kim C, Beckles GL. Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System. Am J Prev Med. 2004 ; 27 (1). 1-7
-
(2004)
Am J Prev Med
, vol.27
, Issue.1
, pp. 1-7
-
-
Kim, C.1
Beckles, G.L.2
-
15
-
-
0035140649
-
Aspirin use among adults with diabetes: Estimates from the Third National Health and Nutrition Examination Survey
-
Rolka DB, Fagot-Campagna A, Narayan KM. Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2001 ; 24 (2). 197-201
-
(2001)
Diabetes Care
, vol.24
, Issue.2
, pp. 197-201
-
-
Rolka, D.B.1
Fagot-Campagna, A.2
Narayan, K.M.3
-
16
-
-
29644436413
-
Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease
-
Stafford RS, Monti V, Ma J. Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease. PLoS Med. 2005 ; 2 (12). e353
-
(2005)
PLoS Med
, vol.2
, Issue.12
, pp. 353
-
-
Stafford, R.S.1
Monti, V.2
Ma, J.3
-
18
-
-
80053344963
-
The "million Hearts" initiative - Preventing heart attacks and strokes
-
Frieden TR, Berwick DM. The "Million Hearts" initiative - preventing heart attacks and strokes. N Engl J Med. 2011 ; 365 (13). e27
-
(2011)
N Engl J Med
, vol.365
, Issue.13
, pp. 27
-
-
Frieden, T.R.1
Berwick, D.M.2
-
19
-
-
64649091484
-
Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting
-
Cuisset T, Frere C, Quilici J, et al. Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting. Am Heart J. 2009 ; 157 (5). 889-893
-
(2009)
Am Heart J
, vol.157
, Issue.5
, pp. 889-893
-
-
Cuisset, T.1
Frere, C.2
Quilici, J.3
-
20
-
-
52049106554
-
Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients
-
Schwartz KA, Schwartz DE, Barber K, Reeves M, De Franco AC. Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. J Transl Med. 2008 ; 6: 46
-
(2008)
J Transl Med
, vol.6
, pp. 46
-
-
Schwartz, K.A.1
Schwartz, D.E.2
Barber, K.3
Reeves, M.4
De Franco, A.C.5
-
21
-
-
10744228434
-
Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin?
-
Cotter G, Shemesh E, Zehavi M, et al. Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?. Am Heart J. 2004 ; 147 (2). 293-300
-
(2004)
Am Heart J
, vol.147
, Issue.2
, pp. 293-300
-
-
Cotter, G.1
Shemesh, E.2
Zehavi, M.3
-
22
-
-
0016805004
-
The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein
-
Roth GJ, Majerus PW. The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein. J Clin Invest. 1975 ; 56 (3). 624-632
-
(1975)
J Clin Invest
, vol.56
, Issue.3
, pp. 624-632
-
-
Roth, G.J.1
Majerus, P.W.2
-
23
-
-
0017893621
-
Inhibition of platelet prostaglandin synthetase by oral aspirin
-
Burch JW, Stanford N, Majerus PW. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest. 1978 ; 61 (2). 314-319
-
(1978)
J Clin Invest
, vol.61
, Issue.2
, pp. 314-319
-
-
Burch, J.W.1
Stanford, N.2
Majerus, P.W.3
-
24
-
-
0025909387
-
Human platelet/erythroleukemia cell prostaglandin G/H synthase: CDNA cloning, expression, and gene chromosomal assignment
-
Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment. FASEB J. 1991 ; 5 (9). 2304-2312
-
(1991)
FASEB J
, vol.5
, Issue.9
, pp. 2304-2312
-
-
Funk, C.D.1
Funk, L.B.2
Kennedy, M.E.3
Pong, A.S.4
Fitzgerald, G.A.5
-
25
-
-
0022396676
-
Clinical pharmacology of platelet cyclooxygenase inhibition
-
Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition. Circulation. 1985 ; 72 (6). 1177-1184
-
(1985)
Circulation
, vol.72
, Issue.6
, pp. 1177-1184
-
-
Patrono, C.1
Ciabattoni, G.2
Patrignani, P.3
-
26
-
-
0029056992
-
The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase
-
Loll PJ, Picot D, Garavito RM. The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase. Nat Struct Biol. 1995 ; 2 (8). 637-643
-
(1995)
Nat Struct Biol
, vol.2
, Issue.8
, pp. 637-643
-
-
Loll, P.J.1
Picot, D.2
Garavito, R.M.3
-
27
-
-
0019988413
-
Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects
-
Patrignani P, Filabozzi P, Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest. 1982 ; 69 (6). 1366-1372
-
(1982)
J Clin Invest
, vol.69
, Issue.6
, pp. 1366-1372
-
-
Patrignani, P.1
Filabozzi, P.2
Patrono, C.3
-
28
-
-
0030795143
-
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina
-
Cipollone F, Patrignani P, Greco A, et al. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation. 1997 ; 96 (4). 1109-1116
-
(1997)
Circulation
, vol.96
, Issue.4
, pp. 1109-1116
-
-
Cipollone, F.1
Patrignani, P.2
Greco, A.3
-
29
-
-
0020692577
-
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
-
FitzGerald GA, Oates JA, Hawiger J, et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983 ; 71 (3). 676-688
-
(1983)
J Clin Invest
, vol.71
, Issue.3
, pp. 676-688
-
-
Fitzgerald, G.A.1
Oates, J.A.2
Hawiger, J.3
-
30
-
-
0030022032
-
A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors
-
Brideau C, Kargman S, Liu S, et al. A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors. Inflamm Res. 1996 ; 45 (2). 68-74
-
(1996)
Inflamm Res
, vol.45
, Issue.2
, pp. 68-74
-
-
Brideau, C.1
Kargman, S.2
Liu, S.3
-
31
-
-
0035246513
-
Cyclooxygenase inhibitors - Current status and future prospects
-
Dannhardt G, Kiefer W. Cyclooxygenase inhibitors - current status and future prospects. Eur J Med Chem. 2001 ; 36 (2). 109-126
-
(2001)
Eur J Med Chem
, vol.36
, Issue.2
, pp. 109-126
-
-
Dannhardt, G.1
Kiefer, W.2
-
32
-
-
0027480087
-
Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs
-
Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1993 ; 268 (9). 6610-6614
-
(1993)
J Biol Chem
, vol.268
, Issue.9
, pp. 6610-6614
-
-
Meade, E.A.1
Smith, W.L.2
Dewitt, D.L.3
-
33
-
-
0027146692
-
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase
-
Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993 ; 90 (24). 11693-11697
-
(1993)
Proc Natl Acad Sci U S A
, vol.90
, Issue.24
, pp. 11693-11697
-
-
Mitchell, J.A.1
Akarasereenont, P.2
Thiemermann, C.3
Flower, R.J.4
Vane, J.R.5
-
34
-
-
0020558909
-
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin
-
Rao GH, Johnson GG, Reddy KR, White JG. Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis. 1983 ; 3 (4). 383-388
-
(1983)
Arteriosclerosis
, vol.3
, Issue.4
, pp. 383-388
-
-
Rao, G.H.1
Johnson, G.G.2
Reddy, K.R.3
White, J.G.4
-
35
-
-
0035924765
-
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
-
Catella-Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med. 2001 ; 345 (25). 1809-1817
-
(2001)
N Engl J Med
, vol.345
, Issue.25
, pp. 1809-1817
-
-
Catella-Lawson, F.1
Reilly, M.P.2
Kapoor, S.C.3
-
36
-
-
0020360347
-
Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity
-
Livio M, Del Maschio A, Cerletti C, de Gaetano G. Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity. Prostaglandins. 1982 ; 23 (6). 787-796
-
(1982)
Prostaglandins
, vol.23
, Issue.6
, pp. 787-796
-
-
Livio, M.1
Del Maschio, A.2
Cerletti, C.3
De Gaetano, G.4
-
37
-
-
17144407991
-
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects
-
Capone ML, Sciulli MG, Tacconelli S, et al. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. J Am Coll Cardiol. 2005 ; 45 (8). 1295-1301
-
(2005)
J Am Coll Cardiol
, vol.45
, Issue.8
, pp. 1295-1301
-
-
Capone, M.L.1
Sciulli, M.G.2
Tacconelli, S.3
-
38
-
-
0030010696
-
Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site
-
Loll PJ, Picot D, Ekabo O, Garavito RM. Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site. Biochemistry. 1996 ; 35 (23). 7330-7340
-
(1996)
Biochemistry
, vol.35
, Issue.23
, pp. 7330-7340
-
-
Loll, P.J.1
Picot, D.2
Ekabo, O.3
Garavito, R.M.4
-
39
-
-
0021022903
-
Arachidonate metabolism in vascular disorders
-
Majerus PW. Arachidonate metabolism in vascular disorders. J Clin Invest. 1983 ; 72 (5). 1521-1525
-
(1983)
J Clin Invest
, vol.72
, Issue.5
, pp. 1521-1525
-
-
Majerus, P.W.1
-
40
-
-
0016748441
-
Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides
-
Hamberg M, Svensson J, Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 ; 72 (8). 2994-2998
-
(1975)
Proc Natl Acad Sci U S A
, vol.72
, Issue.8
, pp. 2994-2998
-
-
Hamberg, M.1
Svensson, J.2
Samuelsson, B.3
-
41
-
-
0025282786
-
Thromboxane biosynthesis and platelet function in type II diabetes mellitus
-
Davi G, Catalano I, Averna M, et al. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med. 1990 ; 322 (25). 1769-1774
-
(1990)
N Engl J Med
, vol.322
, Issue.25
, pp. 1769-1774
-
-
Davi, G.1
Catalano, I.2
Averna, M.3
-
42
-
-
77957113521
-
Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus
-
Mortensen SB, Larsen SB, Grove EL, Kristensen SD, Hvas AM. Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus. Thromb Res. 2010 ; 126 (4). e318 - e322
-
(2010)
Thromb Res
, vol.126
, Issue.4
-
-
Mortensen, S.B.1
Larsen, S.B.2
Grove, E.L.3
Kristensen, S.D.4
Hvas, A.M.5
-
43
-
-
0029875851
-
Passive smoking and platelet thromboxane
-
Schmid P, Karanikas G, Kritz H, et al. Passive smoking and platelet thromboxane. Thromb Res. 1996 ; 81 (4). 451-460
-
(1996)
Thromb Res
, vol.81
, Issue.4
, pp. 451-460
-
-
Schmid, P.1
Karanikas, G.2
Kritz, H.3
-
44
-
-
0026487859
-
Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age
-
Rangemark C, Benthin G, Granstrom EF, Persson L, Winell S, Wennmalm A. Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. Circulation. 1992 ; 86 (5). 1495-1500
-
(1992)
Circulation
, vol.86
, Issue.5
, pp. 1495-1500
-
-
Rangemark, C.1
Benthin, G.2
Granstrom, E.F.3
Persson, L.4
Winell, S.5
Wennmalm, A.6
-
45
-
-
0025845334
-
Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men
-
Wennmalm A, Benthin G, Granstrom EF, Persson L, Petersson AS, Winell S. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation. 1991 ; 83 (5). 1698-1704
-
(1991)
Circulation
, vol.83
, Issue.5
, pp. 1698-1704
-
-
Wennmalm, A.1
Benthin, G.2
Granstrom, E.F.3
Persson, L.4
Petersson, A.S.5
Winell, S.6
-
46
-
-
84898967872
-
-
[package insert]. Ann Arbor, MI: Cayman Chemical Company
-
2 EIA Kit [package insert]. Ann Arbor, MI: Cayman Chemical Company; 2012.
-
(2012)
2 EIA Kit
-
-
-
47
-
-
0035144529
-
A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women
-
Feldman M, Cryer B, Rushin K, Betancourt J. A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women. Clin Appl Thromb Hemost. 2001 ; 7 (1). 53-57
-
(2001)
Clin Appl Thromb Hemost
, vol.7
, Issue.1
, pp. 53-57
-
-
Feldman, M.1
Cryer, B.2
Rushin, K.3
Betancourt, J.4
-
48
-
-
0035875796
-
Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: A placebo-controlled study using a highly sensitive C-reactive protein assay
-
Feldman M, Jialal I, Devaraj S, Cryer B. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol. 2001 ; 37 (8). 2036-2041
-
(2001)
J Am Coll Cardiol
, vol.37
, Issue.8
, pp. 2036-2041
-
-
Feldman, M.1
Jialal, I.2
Devaraj, S.3
Cryer, B.4
-
49
-
-
0026670659
-
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin
-
Tohgi H, Konno S, Tamura K, Kimura B, Kawano K. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke. 1992 ; 23 (10). 1400-1403
-
(1992)
Stroke
, vol.23
, Issue.10
, pp. 1400-1403
-
-
Tohgi, H.1
Konno, S.2
Tamura, K.3
Kimura, B.4
Kawano, K.5
-
50
-
-
77749289650
-
Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery
-
Brambilla M, Parolari A, Camera M, et al. Effect of two doses of aspirin on thromboxane biosynthesis and platelet function in patients undergoing coronary surgery. Thromb Haemost. 2010 ; 103 (3). 516-524
-
(2010)
Thromb Haemost
, vol.103
, Issue.3
, pp. 516-524
-
-
Brambilla, M.1
Parolari, A.2
Camera, M.3
-
51
-
-
0038370082
-
Aspirin dosage and thromboxane synthesis in patients with vascular disease
-
Hart RG, Leonard AD, Talbert RL, et al. Aspirin dosage and thromboxane synthesis in patients with vascular disease. Pharmacotherapy. 2003 ; 23 (5). 579-584
-
(2003)
Pharmacotherapy
, vol.23
, Issue.5
, pp. 579-584
-
-
Hart, R.G.1
Leonard, A.D.2
Talbert, R.L.3
-
52
-
-
83455196215
-
Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: A phase I, randomized, double-blind, placebo-controlled, noninferiority trial
-
Angiolillo DJ, Hwang C, Datto C, Desai B, Sostek M. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial. Clin Ther. 2011 ; 33 (12). 1883-1893
-
(2011)
Clin Ther
, vol.33
, Issue.12
, pp. 1883-1893
-
-
Angiolillo, D.J.1
Hwang, C.2
Datto, C.3
Desai, B.4
Sostek, M.5
-
53
-
-
70350346840
-
The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers
-
Schuijt MP, Huntjens-Fleuren HW, de Metz M, Vollaard EJ. The interaction of ibuprofen and diclofenac with aspirin in healthy volunteers. Br J Pharmacol. 2009 ; 157 (6). 931-934
-
(2009)
Br J Pharmacol
, vol.157
, Issue.6
, pp. 931-934
-
-
Schuijt, M.P.1
Huntjens-Fleuren, H.W.2
De Metz, M.3
Vollaard, E.J.4
-
54
-
-
78649467948
-
Antiplatelet drug interactions
-
Mackenzie IS, Coughtrie MW, MacDonald TM, Wei L. Antiplatelet drug interactions. J Intern Med. 2010 ; 268 (6). 516-529
-
(2010)
J Intern Med
, vol.268
, Issue.6
, pp. 516-529
-
-
Mackenzie, I.S.1
Coughtrie, M.W.2
MacDonald, T.M.3
Wei, L.4
-
55
-
-
77952466833
-
Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2
-
Oldenhof J, Hochberg M, Schiff M, Brune K. Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2. Curr Med Res Opin. 2010 ; 26 (6). 1497-1504
-
(2010)
Curr Med Res Opin
, vol.26
, Issue.6
, pp. 1497-1504
-
-
Oldenhof, J.1
Hochberg, M.2
Schiff, M.3
Brune, K.4
-
56
-
-
16244374947
-
Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers
-
Cryer B, Berlin RG, Cooper SA, Hsu C, Wason S. Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. Clin Ther. 2005 ; 27 (2). 185-191
-
(2005)
Clin Ther
, vol.27
, Issue.2
, pp. 185-191
-
-
Cryer, B.1
Berlin, R.G.2
Cooper, S.A.3
Hsu, C.4
Wason, S.5
-
57
-
-
64649098177
-
Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration
-
Hedegaard SS, Hvas AM, Grove EL, et al. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration. Thromb Res. 2009 ; 124 (1). 96-100
-
(2009)
Thromb Res
, vol.124
, Issue.1
, pp. 96-100
-
-
Hedegaard, S.S.1
Hvas, A.M.2
Grove, E.L.3
-
58
-
-
33747088257
-
Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: A 700-patient study of aspirin resistance
-
Frelinger AL, Furman MI, Linden MD, et al. Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. Circulation. 2006 ; 113 (25). 2888-2896
-
(2006)
Circulation
, vol.113
, Issue.25
, pp. 2888-2896
-
-
Frelinger, A.L.1
Furman, M.I.2
Linden, M.D.3
-
59
-
-
33747168513
-
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers
-
Cox D, Maree AO, Dooley M, Conroy R, Byrne MF, Fitzgerald DJ. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke. 2006 ; 37 (8). 2153-2158
-
(2006)
Stroke
, vol.37
, Issue.8
, pp. 2153-2158
-
-
Cox, D.1
Maree, A.O.2
Dooley, M.3
Conroy, R.4
Byrne, M.F.5
Fitzgerald, D.J.6
-
60
-
-
77953160638
-
A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease
-
Grove EL, Hvas AM, Johnsen HL, et al. A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease. Thromb Haemost. 2010 ; 103 (6). 1245-1253
-
(2010)
Thromb Haemost
, vol.103
, Issue.6
, pp. 1245-1253
-
-
Grove, E.L.1
Hvas, A.M.2
Johnsen, H.L.3
-
61
-
-
38949119325
-
Aspirin "resistance" and risk of cardiovascular morbidity: Systematic review and meta-analysis
-
Krasopoulos G, Brister SJ, Beattie WS, Buchanan MR. Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis. BMJ. 2008 ; 336 (7637). 195-198
-
(2008)
BMJ
, vol.336
, Issue.7637
, pp. 195-198
-
-
Krasopoulos, G.1
Brister, S.J.2
Beattie, W.S.3
Buchanan, M.R.4
-
62
-
-
47749143702
-
Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events - A meta-analysis
-
Sofi F, Marcucci R, Gori AM, Abbate R, Gensini GF. Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events - a meta-analysis. Int J Cardiol. 2008 ; 128 (2). 166-171
-
(2008)
Int J Cardiol
, vol.128
, Issue.2
, pp. 166-171
-
-
Sofi, F.1
Marcucci, R.2
Gori, A.M.3
Abbate, R.4
Gensini, G.F.5
-
63
-
-
34547760330
-
A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease
-
Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J. 2007 ; 28 (14). 1702-1708
-
(2007)
Eur Heart J
, vol.28
, Issue.14
, pp. 1702-1708
-
-
Lordkipanidzé, M.1
Pharand, C.2
Schampaert, E.3
Turgeon, J.4
Palisaitis, D.A.5
Diodati, J.G.6
-
64
-
-
34347340649
-
Evaluation of dose-related effects of aspirin on platelet function: Results from the Aspirin-Induced Platelet Effect (ASPECT) study
-
Gurbel PA, Bliden KP, DiChiara J, et al. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Circulation. 2007 ; 115 (25). 3156-3164
-
(2007)
Circulation
, vol.115
, Issue.25
, pp. 3156-3164
-
-
Gurbel, P.A.1
Bliden, K.P.2
Dichiara, J.3
-
65
-
-
70350441936
-
Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2)
-
Blais N, Pharand C, Lordkipanidze M, Sia YK, Merhi Y, Diodati JG. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thromb Haemost. 2009 ; 102 (2). 404-411
-
(2009)
Thromb Haemost
, vol.102
, Issue.2
, pp. 404-411
-
-
Blais, N.1
Pharand, C.2
Lordkipanidze, M.3
Sia, Y.K.4
Merhi, Y.5
Diodati, J.G.6
-
66
-
-
60049093774
-
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: Implications for aspirin "resistance"
-
Santilli F, Rocca B, De Cristofaro R, et al. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". J Am Coll Cardiol. 2009 ; 53 (8). 667-677
-
(2009)
J Am Coll Cardiol
, vol.53
, Issue.8
, pp. 667-677
-
-
Santilli, F.1
Rocca, B.2
De Cristofaro, R.3
-
67
-
-
60749114799
-
Interindividual variability in the response to oral antiplatelet drugs: A position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
-
Kuliczkowski W, Witkowski A, Polonski L, et al. Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2009 ; 30 (4). 426-435
-
(2009)
Eur Heart J
, vol.30
, Issue.4
, pp. 426-435
-
-
Kuliczkowski, W.1
Witkowski, A.2
Polonski, L.3
|